HollandBIO connects and supports the Dutch
biotech industry. We represent over 200 companies in the field of medical,
agrifood and industrial biotech. And, HollandBIO is growing steadily. Today, we
are proud to welcome AGILeBiotics to the HollandBIO community!
AGILeBiotics is a spin-off company of the
University of Groningen founded by the CEO Dr. Andreas A. Bastian in March
2017. The start-up is committed to contribute to the fight against bacterial
resistance by bringing new therapeutic solutions to hospitalized patients. The
company’s vision is to accelerate the development of novel antibiotics by
employing a proprietary technology named OxaSelect on existing complex natural
product-based antibiotics, which have lower risk for drug resistance. The
synthetic technology gives quick access to next generation drugs with
broad-spectrum activity and improved safety profile.
AGILeBiotics is about to enter the pre-clinical
stage. Their pre-clinical candidates overcome drug-class related bacterial
resistance and have high potency against multidrug-resistant clinical isolates
belonging to the top five pathogens of WHO’s priority list. AGILeBiotics’ goal
is to develop novel antibiotics for the treatment of infections with high death
rate, such as ventilator-associated pneumonia (VAP) and bloodstream infections
(BSI), and neonatal sepsis.
Since 2017, AGILeBiotics has successfully
enquired the pre-seed and seed investment round enabling the identification of
their pre-clinical candidates. Currently, AGILeBiotics is reaching out for
Series A investment round to develop the antibiotic candidate until clinical
For more information please visit AGILeBiotics website.
https://www.hollandbio.nl/wp-content/uploads/2018/01/logo3.png00HollandBIOhttps://www.hollandbio.nl/wp-content/uploads/2018/01/logo3.pngHollandBIO2019-07-09 14:07:372019-07-09 14:16:49HollandBIO welcomes AGILeBiotics as a new member
HollandBIO is de belangenvereniging van biotech bedrijven in Nederland. Samen werken we aan ons toekomstideaal: een maatschappij waarin biotechnologie maximaal bijdraagt aan gezondheid, duurzaamheid en economische groei.
Laan van Nieuw Oost-Indië 131-133
2593 BM Den Haag
Laan van Nieuw Oost-Indië 131 E
2593 BM Den Haag